Carregant...
ACT-21 PRIMARY EXPERIENCE OF NOVOTTF THERAPY FOR THE PATIENTS WITH GBM IN OUR INSTITUTION
BACKGROUND: Based on EF-14 clinical trial, NovoTTF therapy prolong overall survival in the patients with GBM. However, NovoTTF treatment does not become standard therapy because treatment procedures are cumbersome and potentially impose psychological burden on patients who suffer from dismal disease...
Guardat en:
| Publicat a: | Neurooncol Adv |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7213267/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdz039.067 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|